E-Path
Real-time automated cancer casefinding with 99% validated sensitivity
Company profile
Company profile
Inspirata is a leading oncology informatics company that provides end-to-end cancer registry automation solutions for healthcare organizations. With over 20 years of industry innovation, the company serves 270+ hospitals and processes more than 30 million pathology, radiology, and related clinical reports annually. Inspirata's flagship products, E-Path and E-Path Plus, leverage proprietary AI and Natural Language Processing (NLP) technology to automate the most time-intensive aspects of cancer registry management—casefinding and data abstraction. The platform identifies reportable cancer cases in real-time with 98-99% validated accuracy, reducing manual processing time from 30-45 minutes per report to seconds. E-Path Plus auto-populates abstracts with 124+ oncology-specific data elements directly from unstructured clinical documents, allowing oncology data specialists to focus on quality assurance rather than repetitive data entry. Through an exclusive partnership with ONCO, Inspirata delivers the industry's only unified workflow from initial clinical report to final state and federal submission. The company's solutions are deployed on-premises to ensure maximum security and HIPAA compliance, with seamless integration into major EHR, LIS, and RIS systems. Inspirata serves academic medical centers, comprehensive cancer centers, NCI-designated cancer centers, oncology departments, and community oncology practices. The platform addresses critical operational challenges including staffing shortages, registry backlogs, and accreditation requirements while unlocking cancer data for clinical research, trial matching, and patient navigation. With a 96% customer retention rate, Inspirata has established itself as the trusted partner for healthcare organizations seeking to transform their cancer registries from compliance burdens into strategic data assets that drive improved patient outcomes and operational efficiency.
Company description Inspirata official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise deployment with recorded integration context.
Recorded integration context: EHR systems, Hospital Information Systems (HIS), Laboratory Information Systems (LIS), ONCO registry software (exclusive partnership), ONCOLog registry management software, Radiology Information Systems (RIS).
Company milestones
Exclusive partnership with ONCO to provide unified end-to-end cancer data platform combining Inspirata AI's technology with ONCO's registry software and services
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Real-time automated cancer casefinding with 99% validated sensitivity
Automated data abstraction extracting 124+ oncology-specific data elements
Proprietary AI/NLP engine for oncology data extraction and patient-trial matching
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
BMC biology · Jul 15, 2022
Evaluation of freely available data profiling tools for health data research application: a functional evaluation review.BMJ open · May 9, 2022
Network graph representation of COVID-19 scientific publications to aid knowledge discovery.BMJ health & care informatics · Jan 1, 2021
Computer-Aided Laser Dissection: A Microdissection Workflow Leveraging Image Analysis Tools.Journal of pathology informatics · Jan 1, 2018
High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.PloS one · Jan 1, 2018
Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent.Scientific reports · Apr 18, 2017
Clinical validation
NCT04743843 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
From 30-45 minutes per report (manual) to seconds (automated)
98-99% validated accuracy for reportable cancer case detection
96% customer retention rate
Auto-populates 124+ oncology-specific data elements
Improved casefinding completeness and contributed to more accurate and precise diagnosis and cancer classification
Greatly improved casefinding completeness
05 · Leadership
Leadership profiles and professional links from the current Company record.
Catherine Shang
Former Deputy Director of the Victorian Cancer Registry
06 · Company updates
Recent articles published on Inspirata's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.